112 related articles for article (PubMed ID: 16934534)
1. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy.
Sachdeo RC; Gates JR; Bazil CW; Barkley GL; Tatum W; D'Souza J; McCague K
Epilepsy Behav; 2006 Nov; 9(3):457-63. PubMed ID: 16934534
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and tolerability of oxcarbazepine monotherapy.
Martinez W; Ingenito A; Blakeslee M; Barkley GL; McCague K; D'Souza J
Epilepsy Behav; 2006 Nov; 9(3):448-56. PubMed ID: 16962380
[TBL] [Abstract][Full Text] [Related]
3. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
4. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
[TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice.
Pauletto G; Bergonzi P;
Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
[TBL] [Abstract][Full Text] [Related]
7. Determinants of quality of life in patients with refractory focal epilepsy who were not eligible for surgery or who rejected surgery.
Elsharkawy AE; Thorbecke R; Ebner A; May TW
Epilepsy Behav; 2012 Jun; 24(2):249-55. PubMed ID: 22534356
[TBL] [Abstract][Full Text] [Related]
8. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
[TBL] [Abstract][Full Text] [Related]
9. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
10. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
[TBL] [Abstract][Full Text] [Related]
11. [Oxcarbazepine in monotherapy in 324 patients with partial seizures (TRINOVA study)].
Herranz JL; Argumosa A; Salas-Puig J;
Rev Neurol; 2004 Oct 1-15; 39(7):601-6. PubMed ID: 15490343
[TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine treatment in male epilepsy patients improves pre-existing sexual dysfunction.
Luef G; Krämer G; Stefan H
Acta Neurol Scand; 2009 Feb; 119(2):94-9. PubMed ID: 18705676
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
14. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures.
Donati F; Gobbi G; Campistol J; Rapatz G; Daehler M; Sturm Y; Aldenkamp AP;
Seizure; 2007 Dec; 16(8):670-9. PubMed ID: 17574448
[TBL] [Abstract][Full Text] [Related]
15. Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch.
Albani F; Grassi B; Ferrara R; Turrini R; Baruzzi A;
Seizure; 2004 Jun; 13(4):254-63. PubMed ID: 15121136
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
17. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia.
Gomez-Arguelles JM; Dorado R; Sepulveda JM; Herrera A; Arrojo FG; Aragón E; Huete CR; Terrón C; Anciones B
J Clin Neurosci; 2008 May; 15(5):516-9. PubMed ID: 18378142
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in patients with partial-onset seizures under adjunctive therapy with zonisamide: results from a prospective non-interventional surveillance study.
Helmstaedter C; Stefan H; Witt JA
Epileptic Disord; 2011 Sep; 13(3):263-76. PubMed ID: 21914589
[TBL] [Abstract][Full Text] [Related]
19. Oxcarbazepine: a review of its use in children with epilepsy.
Bang L; Goa K
Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
[TBL] [Abstract][Full Text] [Related]
20. Spotlight on oxcarbazepine in epilepsy.
Bang LM; Goa KL
CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
